应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
RGEN Repligen Corporation
盘前交易 07-27 08:15:26 EDT
131.96
-5.64
-4.10%
盘前
133.33
+1.37
+1.04%
07:09 EDT
最高
138.13
最低
131.82
成交量
135.99万
今开
138.13
昨收
137.60
日振幅
4.59%
总市值
74.28亿
流通市值
70.36亿
总股本
5,629万
成交额
1.81亿
换手率
2.55%
流通股本
5,332万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
若交易在特定情况下终止，Biolife或需向Repligen支付5900万美元终止费
美股速递 · 07-22
若交易在特定情况下终止，Biolife或需向Repligen支付5900万美元终止费
Repligen斥资15亿美元收购BioLife，以扩大细胞治疗业务
老虎资讯综合 · 07-22
Repligen斥资15亿美元收购BioLife，以扩大细胞治疗业务
Repligen将收购BioLife Solutions，通过市场领先的生物保存介质拓展其细胞疗法能力
美股速递 · 07-22
Repligen将收购BioLife Solutions，通过市场领先的生物保存介质拓展其细胞疗法能力
异动解读｜Repligen Corporation盘中上涨6.57%，报147.52美元
行情直击 · 06-26
异动解读｜Repligen Corporation盘中上涨6.57%，报147.52美元
谷歌母公司Alphabet披露持仓变动：增持PayPay与CME集团，清仓德康医疗
投资观察 · 05-08
谷歌母公司Alphabet披露持仓变动：增持PayPay与CME集团，清仓德康医疗
财报前瞻｜Repligen Corporation本季度营收预计增17.36%，机构观点偏正面
财报Agent · 04-28
财报前瞻｜Repligen Corporation本季度营收预计增17.36%，机构观点偏正面
Repligen公布2025年第四季度及全年财报，并发布2026年财务展望
美股速递 · 02-24
Repligen公布2025年第四季度及全年财报，并发布2026年财务展望
财报前瞻｜Repligen Corporation本季度营收预计增15.05%，机构观点偏谨慎
财报Agent · 02-17
财报前瞻｜Repligen Corporation本季度营收预计增15.05%，机构观点偏谨慎
Repligen Corporation盘中异动 股价大跌5.00%报138.81美元
市场透视 · 02-06
Repligen Corporation盘中异动 股价大跌5.00%报138.81美元
Repligen Corporation盘中异动 早盘快速拉升5.20%
市场透视 · 02-03
Repligen Corporation盘中异动 早盘快速拉升5.20%
Repligen Corporation盘中异动 快速下跌5.17%报147.65美元
市场透视 · 2025-03-10
Repligen Corporation盘中异动 快速下跌5.17%报147.65美元
Repligen Corporation盘中异动 股价大跌5.16%报147.37美元
市场透视 · 2025-03-04
Repligen Corporation盘中异动 股价大跌5.16%报147.37美元
Repligen Corporation盘中异动 下午盘股价大涨5.01%
市场透视 · 2025-02-25
Repligen Corporation盘中异动 下午盘股价大涨5.01%
小摩：维持Repligen(RGEN.US)评级，由增持调整至增持评级, 目标价由190.00美元调整至200.00美元。
金融界 · 2025-02-21
小摩：维持Repligen(RGEN.US)评级，由增持调整至增持评级, 目标价由190.00美元调整至200.00美元。
加拿大投资银行集团：维持Repligen(RGEN.US)评级，由持有调整至持有评级, 目标价由165.00美元调整至170.00美元。
金融界 · 2025-02-21
加拿大投资银行集团：维持Repligen(RGEN.US)评级，由持有调整至持有评级, 目标价由165.00美元调整至170.00美元。
异动解读 | Repligen公司2024年Q4财报超预期,股价盘中涨逾9%
异动解读 · 2025-02-21
异动解读 | Repligen公司2024年Q4财报超预期,股价盘中涨逾9%
异动解读 | Repligen公司盘前大涨9.47%，业绩超预期带来市场利好
异动解读 · 2025-02-20
异动解读 | Repligen公司盘前大涨9.47%，业绩超预期带来市场利好
Repligen 2024年第四季度调整后每股收益0.44美元，超出预期的0.41美元，销售额为1.6755亿美元，低于预期的1.6767亿美元
财报速递 · 2025-02-20
Repligen 2024年第四季度调整后每股收益0.44美元，超出预期的0.41美元，销售额为1.6755亿美元，低于预期的1.6767亿美元
Repligen Corporation盘中异动 下午盘急速下跌5.10%
市场透视 · 2025-01-30
Repligen Corporation盘中异动 下午盘急速下跌5.10%
Repligen Corporation盘中异动 快速上涨6.24%报178.50美元
市场透视 · 2025-01-28
Repligen Corporation盘中异动 快速上涨6.24%报178.50美元
加载更多
公司概况
公司名称：
Repligen Corporation
所属市场：
NASDAQ
上市日期：
--
主营业务：
Repligen Corporation成立于1981年5月。该公司是生物制剂生产关键产品的领先供应商。公司根据长期供应协议为主要生命科学公司生产Protein A，同时也直接向终端用户销售产品，供其生产工艺使用。公司还将其在生物制品开发方面的专业知识应用于SecreFlo的研发。SecreFlo是公司正在开发的一种合成人激素，旨在作为一种新型显像剂用于诊断胰腺炎以及潜在的多种胰腺疾病。该公司目前还有两项针对弗里德赖希氏共济失调和脊髓性肌萎缩症的早期中枢神经系统罕见病项目正在进行中，并已进入I期临床试验阶段。此外，该公司已将部分知识产权授权给Bristol-Myers Squibb Company，并从该公司在美国销售的Orencia产品净销售额中获得特许权使用费。
发行价格：
--
{"stockData":{"symbol":"RGEN","market":"US","secType":"STK","nameCN":"Repligen Corporation","latestPrice":131.96,"timestamp":1784923200000,"preClose":137.6,"halted":0,"volume":1359904,"hourTrading":{"tag":"盘前","latestPrice":133.33,"preClose":131.96,"latestTime":"07:09 EDT","volume":37,"amount":4928.62533,"timestamp":1785150587162,"change":1.37,"changeRate":0.010382,"amplitude":0.019953},"delay":0,"changeRate":-0.04098837209302316,"floatShares":53317686,"shares":56290749,"eps":0.91,"marketStatus":"盘前交易","change":-5.64,"latestTime":"07-27 08:15:26 EDT","open":138.13,"high":138.13,"low":131.82,"amount":181313960.464,"amplitude":0.045858,"askPrice":161.08,"askSize":100,"bidPrice":111.76,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.91,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785159000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":131.96,"preHourTrading":{"tag":"盘前","latestPrice":133.33,"preClose":131.96,"latestTime":"07:09 EDT","volume":37,"amount":4928.62533,"timestamp":1785150587162,"change":1.37,"changeRate":0.010382,"amplitude":0.019953},"postHourTrading":{"tag":"盘后","latestPrice":131.96,"preClose":131.96,"latestTime":"19:34 EDT","volume":24514,"amount":3234866.38,"timestamp":1784936051908,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7215519981008616,"impliedVol":0.5598,"impliedVolPercentile":0.864},"requestUrl":"/m/hq/s/RGEN","defaultTab":"news","newsList":[{"id":"1183199218","title":"若交易在特定情况下终止，Biolife或需向Repligen支付5900万美元终止费","url":"https://stock-news.laohu8.com/highlight/detail?id=1183199218","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183199218?lang=zh_cn&edition=full","pubTime":"2026-07-22 21:04","pubTimestamp":1784725473,"startTime":"0","endTime":"0","summary":"根据相关协议条款，在某些特定情形下，如果交易被终止，Biolife可能被要求向Repligen Corporation支付一笔高达5900万美元的终止费用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261612.USD","BK4121","RGEN","LU0205194284.USD","LU0205193047.USD","LU0012050646.USD","LU0757428866.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169933349","title":"Repligen斥资15亿美元收购BioLife，以扩大细胞治疗业务","url":"https://stock-news.laohu8.com/highlight/detail?id=1169933349","media":"老虎资讯综合","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169933349?lang=zh_cn&edition=full","pubTime":"2026-07-22 20:15","pubTimestamp":1784722547,"startTime":"0","endTime":"0","summary":"Repligen Corp周三表示，将以现金加股票方式收购BioLife Solutions，交易估值约为15亿美元，以扩大这家制药设备供应商在快速增长的细胞治疗市场的业务布局。此次收购将使Repligen获得BioLife在细胞保存技术方面的能力，可用于整个生产流程及供应链中的细胞保存，同时还将获得其细胞处理工具产品组合以及利润率较高的耗材业务。根据交易条款，BioLife股东每持有一股BioLife股票，将获得11.25美元现金以及0.1442股Repligen股票，对应BioLife每股估值约为31美元，较该公司上一交易日收盘价溢价约6.2%。","market":"us","thumbnail":"https://community-static.tradeup.com/news/7cb15f3cc7d8054b7829af808afcb782","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/7cb15f3cc7d8054b7829af808afcb782"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Repligen斥资15亿美元收购BioLife，以扩大细胞治疗业务","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN","BLFS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1174553516","title":"Repligen将收购BioLife Solutions，通过市场领先的生物保存介质拓展其细胞疗法能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1174553516","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174553516?lang=zh_cn&edition=full","pubTime":"2026-07-22 18:02","pubTimestamp":1784714521,"startTime":"0","endTime":"0","summary":"Repligen Corporation（RGEN）已同意收购BioLife Solutions Inc.（BLFS），此举旨在通过整合后者市场领先的生物保存介质产品，显著增强其在细胞治疗领域的技术与业务能力。这项交易将Repligen在生物工艺领域的专长与BioLife Solutions在细胞与基因治疗低温保存解决方案方面的领导地位相结合，预计将创造更完整的供应链产品组合，服务于快速增长的先进疗法市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLFS","LU1169590202.USD","LU0205194284.USD","BK4198","LU1169589451.USD","LU0106261612.USD","LU0757428866.USD","RGEN","LU0205193047.USD","LU0012050646.USD","LU1815336091.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134464808","title":"异动解读｜Repligen Corporation盘中上涨6.57%，报147.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134464808","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134464808?lang=zh_cn&edition=full","pubTime":"2026-06-26 00:15","pubTimestamp":1782404130,"startTime":"0","endTime":"0","summary":"6月26日，Repligen Corporation盘中上涨6.57%，报147.52美元/股，成交额1.05亿美元。Repligen Corporation所在的生命科学工具和服务行业中，整体表现强势，个股中，Techne Corporation涨19.7%，赛默飞世尔涨3.78%，丹纳赫涨3.12%，Tempus AI涨5.04%，Illumina涨3.25%。Repligen Corporation是生物制剂生产关键产品的领先供应商，专注于生物工艺技术，为主要生命科学公司生产Protein A等核心产品，同时直接向终端用户销售生物加工设备和用品。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139383641","title":"谷歌母公司Alphabet披露持仓变动：增持PayPay与CME集团，清仓德康医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1139383641","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139383641?lang=zh_cn&edition=full","pubTime":"2026-05-08 18:36","pubTimestamp":1778236606,"startTime":"0","endTime":"0","summary":"根据最新提交的监管文件显示，Alphabet公司在截至2026年3月31日的季度内对其投资组合进行了显著调整。这家科技巨头披露持有PayPay公司310万份赞助存托凭证，同时增持Planet Labs Pbc公司10.4%的A类股份，使其总持股量达到3520万股。在金融领域，Alphabet报告持有芝加哥商品交易所约350万股股份。此外，Alphabet还披露持有Ethos Technologies公司380万份A类股份，同时将其在Revolution Medicines公司的持股比例削减1.6%，目前持有330万股。这些持仓变动均以2025年12月31日为基准进行对比。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF631.EUR","LU1119994496.HKD","LU0980610538.SGD","IE0034235188.USD","LU0943347566.SGD","LU0276348264.USD","LU0787776722.HKD","LU1121112475.USD","IE00BLSP4239.USD","LU0289739343.SGD","LU2095319765.USD","LU2326559502.SGD","LU0731783394.SGD","LU0889566641.SGD","BK4581","LU0107464264.USD","SG9999000418.SGD","LU1951198990.SGD","LU1267930573.SGD","LU1400636657.SGD","LU2756315318.SGD","SG9999014906.USD","BK4527","SG9999015978.USD","IE0034235303.USD","LU1935042991.SGD","LU1201861165.SGD","LU0823417737.USD","LU1852331112.SGD","LU1732799900.SGD","LU1064131342.USD","LU2362541273.HKD","LU2275660780.HKD","LU2097829019.USD","LU0511384066.AUD","LU2087625088.SGD","IE00B19Z8W00.USD","LU2404859741.USD","BK4533","SG9999014880.SGD","LU0642271901.SGD","LU0215105999.USD","LU0345768153.USD","LU2023250504.SGD","IE000M9KFDE8.USD","LU0345769631.USD","LU2491050071.SGD","IE000SO60NU8.SGD","LU0950375773.USD","IE00BK4W5L77.USD","LU0772969993.USD","BK4112","BK4550","LU2077746001.SGD","LU2433249047.HKD","LU0143551892.USD","LU1868836591.USD","LU2954938101.SGD","LU1202635105.USD","LU2430703251.USD","LU2028103732.USD","LU2065171402.SGD","LU2271345857.HKD","LU0964807845.USD","LU1839511570.USD","LU0006306889.USD","LU1894683264.USD","IE00BJTD4N35.SGD","LU0882574139.USD","LU0106261372.USD","LU1599440770.SGD","LU0225283273.USD","LU0289960550.SGD","LU2168564222.USD","LU2242649171.HKD","LU2430703178.SGD","LU1116320901.HKD","LU0354030438.USD","IE00BDCRKT87.USD","LU0211326755.USD","LU1989764748.USD","LU2404859667.USD","IE00B19Z3581.USD","LU0353189763.USD","IE00BWXC8680.SGD","LU1791710582.SGD","LU1804176565.USD","LU0061474960.USD","LU1303367103.USD","IE00BVYPNV92.GBP","GOOGL","LU0174119429.USD","LU1868837300.USD","LU0994945656.USD","BK4602","LU0557290698.USD","LU1815336091.USD","BK4123","LU1974910355.USD","LU2054465674.USD","IE0034235295.USD","IE00BKPKM429.USD","LU2360106780.USD","LU0130102774.USD","LU0211331839.USD","LIFE","LU1221951129.SGD","LU1032955483.USD","IE00B3PB1722.GBP","LU1116320737.USD","SG9999014898.SGD","LU2063271972.USD","LU0823417653.USD","LU2381873111.SGD","GOOP","LU1923623000.USD","LU2023250843.SGD","IE0004091025.USD","LU1670627923.USD","RGEN","IE00B3T34201.USD","LU2213496289.HKD","LU2417539215.USD","IE00BMPRXQ63.HKD","LU2250418816.HKD","LU2265009873.SGD","LU1221951046.USD","WGS","LU0690374961.EUR","LU0823421416.USD","LU2106854487.HKD","LU0127658192.USD","LU2756315664.SGD","LU0203345920.USD","IE00BN8TJ469.HKD","LU1506573853.SGD","BK4532","LU0302445910.USD","LU0348723411.USD","LU1400636491.USD","SG9999018857.SGD","LU0203347892.USD","BK4561","IE00B19Z3B42.SGD","LU0345774631.USD","LU2456880835.USD","LU1003077747.HKD","GB00B4LPDJ14.GBP","PAYP","LU0211327993.USD","LU0820561909.HKD","CME","IE00B19Z9505.USD","IE000MB6IJN5.SGD","LU1718418525.SGD","LU1585245621.USD","LU2750360997.AUD","LU0477156953.USD","LU1642822529.SGD","LU0868494708.USD","IE00B19Z8X17.USD","LU2125909247.SGD","LU1935043023.USD","LU0494093205.USD","BK4592","IE00B7SZLL34.SGD","LU2168564149.EUR","LU0742537680.HKD","LU2360032135.SGD","LU2065171311.SGD","LU1989764664.SGD","LU2087621335.USD","BK4576","LU0077335932.USD","LU2237438978.USD","LU1880398554.USD","LU2168564065.EUR","IE00BSNM7G36.USD","LU0158827948.USD","LU1145028129.USD","IE0000B7K699.USD","HK0000532082.HKD","LU0080751232.USD","LU1699723380.USD","SG9999017495.SGD","SG9999018865.SGD","LU1366333091.USD","BK4007","LU0106261612.USD","LU2191332357.HKD","LU2506951958.HKD","SGXZ31699556.SGD","LU1323610961.USD","LU1868836914.USD","LU0345770308.USD","LU1496350171.SGD","LU0690374615.EUR","IE00BKDWB100.SGD","LU1430594728.SGD","LU1720051017.SGD","GOOX","LU2471134952.CNY","LU0949170772.SGD","LU0738911758.USD","LU0444973449.USD","IE00BDRTCR15.USD","LU1674673691.USD","LU0211326839.USD","LU0130103400.USD","BK4121","LU0256863902.USD","LU1917777945.USD","LU1645745479.HKD","LU2168563687.JPY","IE00BLSP4452.SGD","LU1778281490.HKD","BK4566","SG9999015945.SGD","LU1670756490.USD","LU0708994859.HKD","LU1066051225.USD","LU1267930730.SGD","LU0012050646.USD","LU0210533765.USD","LU1880398471.USD","IE00BFMHRM44.USD","IE0004086264.USD","LU0957808578.USD","LU0234570918.USD","BK4574","LU1481011911.USD","LU2505996681.GBP","LU1046421795.USD","LU0070217475.USD","BK4612","LU0149725797.USD","IE00BYXW3230.USD","LU1629891620.HKD","LU2506952097.USD","LU2098885051.SGD","LU2506952170.USD","LU0823434740.USD","LU0868494617.USD","LU0310800379.SGD","LU0234572021.USD","LU1435385759.SGD","LU1201861249.SGD","LU1815333072.USD","LU0444971666.USD","IE0001KFT4U8.USD","LU1228905037.USD","LU0138981039.USD","LU2236285917.USD","LU0057025933.USD","LU2242650005.HKD","LU0170899867.USD","FULC","LU2210149790.SGD","LU0251132253.USD","LU1988902786.USD","LU0795875086.SGD","LU1815336760.USD","BK4548","IE00B1BXHZ80.USD","LU2210150020.SGD","LU1989772923.USD","LU1571399168.USD","LU0823434583.USD","LU0061474705.USD","LU2420271590.USD","IE00BMPRXR70.SGD","SGXZ81514606.USD","LU0640476718.USD","LU2602419157.SGD","LU0052756011.USD","LU2746668461.USD","GOOY","LU2097344431.USD","LU2860962120.EUR","GGLL","LU0466842654.USD","LU0795875169.SGD","LU2023250330.USD","LU0476273544.USD","LU2362541513.USD","BK4196","LU0198837287.USD","LU0689626769.HKD","LU0256863811.USD","LU0477156797.USD","LU1244550221.USD","LU0672654240.SGD","LU2471134523.USD","DXCM","LU2065169927.USD","LU1261432733.SGD","LU0320765489.SGD","LU0323591593.USD","LU1914381329.SGD","LU0109391861.USD","SG9999015952.SGD","BK4077","LU2211815571.USD","LU2471134796.USD","BK4585","IE000BZT7R73.USD","LU1196500208.SGD","PLU","LU2505996509.AUD","LU1153585028.USD","LU0942090050.USD","LU2506951875.HKD","LU0342679015.USD","LU0792757196.USD","LU2092627202.USD","LU1551013342.USD","LU0661504455.SGD","IE00BK4W5M84.HKD","LU0757428866.USD","LU0648001328.SGD","LU0310799852.SGD","LU1633808545.USD","BK4139","LU1989772840.SGD","LU2471134879.HKD","BK4579","BK4503","LU2089284900.SGD","LU2462591277.SGD","RVMD","IE00BVYPNW00.USD","LU2125154935.USD","GGLS","LU0208291251.USD","LU0320765059.SGD","LU1551013425.SGD","GB00B4QBRK32.GBP","BK4514","LU2357305700.SGD","LU2362540622.SGD","LU0912757837.SGD","LU2023251221.USD","IE00BQXX3C00.GBP","LU1228905540.USD","LU1066051498.USD","LU1366192091.USD","LU2111349929.HKD","LU2491049909.HKD","HK0000304805.HKD","BK4227","LU0553294199.USD","LU0048573561.USD","LU0683600562.USD","LU0094547139.USD","LU1923622614.USD","LU1720051108.HKD","LU1280957306.USD","LU0354030511.USD","LU0784385840.USD","LU2592432038.USD","BK4598","LU1548497426.USD","LU1670628061.USD","LU0426412945.USD","LU1868836757.USD","LU0265550359.USD","LU0417517546.SGD","BK4588","LU0211328371.USD","LU0823421333.USD","LU0130518102.USD","LU2125909593.SGD","LU1935042488.USD","LU1244550577.SGD","IE00BZ1G4Q59.USD","LU0976567544.SGD","LU1509826696.USD","BK4504","LU0130517989.USD","LU0011850046.USD","LU0048584097.USD","LU2403377893.USD","LU1267930227.SGD","LU1674673428.USD","LU0310800965.SGD","LU0267386448.USD","LU1084165304.USD","LU2097344357.USD","LU0708995401.HKD","LU0784384876.USD","LU0472753341.HKD","LU0426417589.USD","LU1267930813.SGD","BK4573","LU0124676726.USD","IE000WAW04H5.SGD","LU1066053197.SGD","LU0175139822.USD","LU1803068623.USD","LU2347655156.SGD","LU0345769128.USD","LU1868837136.USD","LU2065170008.USD","SG9999015986.USD","BK4173","LU0820561818.USD","LU1066051811.HKD","HK0000304797.USD","LU0314104364.USD","SG9999014914.USD","LU1244550494.USD","LU2244417387.USD","LU2750360641.GBP","LU1043141123.HKD","BK4538","LU0158827781.USD","LU0070302665.USD","LU0029864427.USD","LU1823568750.SGD","LU1316542783.SGD","IE00BDGV0183.EUR","LU0128525929.USD","LU0251131958.USD","IE00B1XK9C88.USD","LU2999663052.SGD","LU2746668974.SGD","LU0820562030.AUD","LU0154236417.USD","LU0689472784.USD","LU0061475181.USD","LU1301847155.USD","LU2247934214.USD","LU0545039389.USD","LU0128525689.USD","LU0312595415.SGD","IE000F7OJYX1.SGD","LU2133065610.SGD","LU2092937148.SGD","PL","LU1732800096.USD","LU0187121727.USD","GOU","LU0784385170.HKD","LU1059921491.USD","LU1481011671.HKD","LU2168564495.EUR","IE00BJLML261.HKD","LU0648000940.SGD","LU2462157665.USD","LU0496365809.HKD","LU1496350502.SGD","LU0545562505.USD","GOOW","LU2125154778.USD","LU0097036916.USD","LU0985320562.USD","LU0316494557.USD","LU0528227936.USD","LU0784383803.USD","LU0345770993.USD","LU0251142724.SGD","LU0265550946.USD","IE00BMPRXN33.USD","LU0949170426.SGD","LU0957791311.USD","LU0314106906.USD","LU0345768740.USD","IE00BBT3K403.USD","LU0069063385.USD","IE00BJTD4V19.USD","LU2089283258.USD","LU1951200564.SGD","HK0000819398.USD","LU0742534661.SGD","LU1267930490.SGD","IE00BQXX3F31.USD","LU0353189680.USD","LU2462591350.SGD","IE00B42XCP33.USD","LU1043141396.HKD","LU1400636574.HKD","LU0096362180.USD","LU0157215616.USD","IE0002270589.USD","BK4082","LU1791710400.SGD","LU0731783048.USD","LU0289961442.SGD","SGXZ99366536.SGD","LU1235294995.USD","BK4551","BK4543","LU1935042215.USD","SGXZ51526630.SGD","LU0266013472.USD","LU1935043536.SGD","BK4534","LU0345774391.USD","LU2264538146.SGD","IE00BHPRN162.USD","LU2491050154.USD","LU0096364046.USD","LU0056508442.USD","LU1429558221.USD","BK4563","LU2430703095.HKD","IE00BQXX3D17.EUR","LU1232071149.USD","LU1894683348.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146420854","title":"财报前瞻｜Repligen Corporation本季度营收预计增17.36%，机构观点偏正面","url":"https://stock-news.laohu8.com/highlight/detail?id=1146420854","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146420854?lang=zh_cn&edition=full","pubTime":"2026-04-28 11:49","pubTimestamp":1777348196,"startTime":"0","endTime":"0","summary":"Repligen Corporation将于2026年05月05日发布财报，市场关注收入与盈利修复的力度及关键产品线表现。上季度公司实现营收1.98亿美元，同比增长18.12%，毛利率52.46%，归属于母公司净利润为1,328.70万美元，净利率6.71%，调整后每股收益为0.49美元，同比增长11.36%。上季度毛利率为52.46%，结合本季度收入预计同比增长17.36%，若制造稼动率提升与原材料价格稳定，单位制造成本下压将带来毛利率边际改善的空间。近期主流机构对Repligen Corporation观点偏正面，看多意见占比更高。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Repligen Corporation本季度营收预计增17.36%，机构观点偏正面","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131125670","title":"Repligen公布2025年第四季度及全年财报，并发布2026年财务展望","url":"https://stock-news.laohu8.com/highlight/detail?id=1131125670","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131125670?lang=zh_cn&edition=full","pubTime":"2026-02-24 20:31","pubTimestamp":1771936317,"startTime":"0","endTime":"0","summary":"生物工艺技术公司Repligen Corporation（股票代码：RGEN）近日披露了2025财年第四季度及全年业绩报告，同时向市场公布了2026财年的财务预期。此次披露涵盖了公司关键财务指标及未来业务发展方向，为投资者提供最新运营参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN","BK4121","LU1815336091.USD","LU0012050646.USD","LU0106261612.USD","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100749997","title":"财报前瞻｜Repligen Corporation本季度营收预计增15.05%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1100749997","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100749997?lang=zh_cn&edition=full","pubTime":"2026-02-17 11:09","pubTimestamp":1771297755,"startTime":"0","endTime":"0","summary":"Repligen Corporation将于2026年02月24日发布最新季度财报，市场关注营收与利润恢复的节奏以及主营业务动能。市场一致预期本季度营收为1.93亿美元，同比增长15.05%；毛利率预测未披露；净利润或净利率预测未披露；调整后每股收益为0.44美元，同比增长7.25%。上季度营收为1.89亿美元，同比增长21.94%；毛利率为53.24%；归属于母公司股东的净利润为1,491.10万美元，环比增长率为30.00%；净利率为7.90%；调整后每股收益为0.46美元，同比增长6.98%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜Repligen Corporation本季度营收预计增15.05%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609759947","title":"Repligen Corporation盘中异动 股价大跌5.00%报138.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609759947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609759947?lang=zh_cn&edition=full","pubTime":"2026-02-06 03:36","pubTimestamp":1770320215,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日03时36分，Repligen Corporation股票出现异动，股价急速跳水5.00%。截至发稿，该股报138.81美元/股，成交量42.55万股，换手率0.76%，振幅5.58%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.73%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗、细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206033655a4815917&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206033655a4815917&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","LU0106261612.USD","BK4121","LU1815336091.USD","LU0757428866.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608505683","title":"Repligen Corporation盘中异动 早盘快速拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608505683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608505683?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:32","pubTimestamp":1770129128,"startTime":"0","endTime":"0","summary":"北京时间2026年02月03日22时32分，Repligen Corporation股票出现异动，股价急速上涨5.20%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.11%。其相关个股中，Zentek Ltd.、Repligen Corporation、Femasys Inc.涨幅较大，Glucotrack, Inc.、Microbot Medical Inc.、AngioDynamics较为活跃，换手率分别为1.11%、0.31%、0.22%，振幅较大的相关个股有Retractable Technologies, Inc.、Anbio Biotechnology、Repligen Corporation，振幅分别为6.41%、4.95%、4.28%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203223208953fa50f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203223208953fa50f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0012050646.USD","RGEN","LU1815336091.USD","BK4121","LU0757428866.USD","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518827601","title":"Repligen Corporation盘中异动 快速下跌5.17%报147.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518827601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518827601?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:52","pubTimestamp":1741614761,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时52分，Repligen Corporation股票出现异动，股价急速跳水5.17%。截至发稿，该股报147.65美元/股，成交量7.3314万股，换手率0.13%，振幅2.90%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为1.40%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215241abf30469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310215241abf30469&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0757428866.USD","RGEN","BK4121","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517605707","title":"Repligen Corporation盘中异动 股价大跌5.16%报147.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517605707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517605707?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:47","pubTimestamp":1741103262,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时47分，Repligen Corporation股票出现波动，股价大幅下跌5.16%。截至发稿，该股报147.37美元/股，成交量11.4499万股，换手率0.20%，振幅4.70%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为1.24%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304234742a25f19d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304234742a25f19d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","BK4121","LU0757428866.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514703863","title":"Repligen Corporation盘中异动 下午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514703863?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:06","pubTimestamp":1740427594,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时06分，Repligen Corporation股票出现波动，股价快速拉升5.01%。截至发稿，该股报166.96美元/股，成交量47.4486万股，换手率0.85%，振幅5.20%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.23%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502250406349891370c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502250406349891370c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","LU1815336091.USD","LU0757428866.USD","RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513097291","title":"小摩：维持Repligen(RGEN.US)评级，由增持调整至增持评级, 目标价由190.00美元调整至200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513097291","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513097291?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:22","pubTimestamp":1740151334,"startTime":"0","endTime":"0","summary":"小摩：维持Repligen(RGEN.US)评级，由增持调整至增持评级, 目标价由190.00美元调整至200.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21232248320493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513262262","title":"加拿大投资银行集团：维持Repligen(RGEN.US)评级，由持有调整至持有评级, 目标价由165.00美元调整至170.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513262262","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513262262?lang=zh_cn&edition=full","pubTime":"2025-02-21 20:40","pubTimestamp":1740141632,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Repligen(RGEN.US)评级，由持有调整至持有评级, 目标价由165.00美元调整至170.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21204048318756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103076426","title":"异动解读 | Repligen公司2024年Q4财报超预期,股价盘中涨逾9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103076426","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103076426?lang=zh_cn&edition=full","pubTime":"2025-02-21 03:48","pubTimestamp":1740080910,"startTime":"0","endTime":"0","summary":"上市生物科技公司Repligen(RGEN)今日盘中大涨9.48%,引发市场关注。这主要是由于公司新发布的2024年第四季度财报数据好于预期,带来了利好消息。\n\n根据财报显示,Repligen公司第四季度每股收益为0.44美元,超出了分析师预期的0.41美元。尽管公司当季销售额略低于预期,但盈利能力的显著提升,显示了公司良好的运营状况。\n\n分析人士认为,Repligen公司业绩超预期,增强了投资者对公司长期发展前景的信心。市场预期该公司将继续保持良好的增长动能,成为资本市场中的投资热点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179131861","title":"异动解读 | Repligen公司盘前大涨9.47%，业绩超预期带来市场利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1179131861","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179131861?lang=zh_cn&edition=full","pubTime":"2025-02-20 21:54","pubTimestamp":1740059678,"startTime":"0","endTime":"0","summary":"上市生物科技公司Repligen(RGEN)今日盘前大涨9.47%,引发了市场投资者的广泛关注。\n\n消息面上,Repligen公司最新公布的2024年第四季度财报显示,公司当季每股收益为0.44美元,超出了分析师预期的0.41美元,同时公司销售额也略高于去年同期。尽管销售额低于分析师预期,但盈利能力的增长仍彰显出公司良好的运营状况。\n\n分析人士认为,Repligen公司的季度业绩好于市场预期,显示公司具有强劲的利润增长动力,这增强了投资者对公司长期前景的信心,从而刺激了公司股价在盘前大幅走高。展望未来,公司有望继续保持良好的业绩增长,成为资本市场的投资热点。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124711795","title":"Repligen 2024年第四季度调整后每股收益0.44美元，超出预期的0.41美元，销售额为1.6755亿美元，低于预期的1.6767亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124711795","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124711795?lang=zh_cn&edition=full","pubTime":"2025-02-20 20:39","pubTimestamp":1740055154,"startTime":"0","endTime":"0","summary":"Repligen 报告其季度每股收益为0.44美元，高于分析师普遍预期的0.41美元，高出7.32%。公司报告其季度销售额为1.6755亿美元，低于分析师普遍预期的1.6767亿美元，低出0.07%。与去年同期的销售额1.6662亿美元相比，增长了0.56%。以上内容来自Benzinga Earnings专栏，原文如下：Repligen reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.41 by 7.32 percent. This is a 8.33 percent decrease over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $167.55 million which missed the analyst consensus estimate of $167.67 mill","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Repligen 2024年第四季度调整后每股收益0.44美元，超出预期的0.41美元，销售额为1.6755亿美元，低于预期的1.6767亿美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507650584","title":"Repligen Corporation盘中异动 下午盘急速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507650584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507650584?lang=zh_cn&edition=full","pubTime":"2025-01-30 03:06","pubTimestamp":1738177586,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日03时06分，Repligen Corporation股票出现波动，股价快速下挫5.10%。截至发稿，该股报165.36美元/股，成交量46.3634万股，换手率0.83%，振幅5.18%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.28%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130030627a2339427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130030627a2339427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","LU1815336091.USD","LU0757428866.USD","RGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506751752","title":"Repligen Corporation盘中异动 快速上涨6.24%报178.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506751752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506751752?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074672,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分，Repligen Corporation股票出现异动，股价大幅拉升6.24%。截至发稿，该股报178.50美元/股，成交量3.5001万股，换手率0.06%，振幅0.00%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.61%。其相关个股中，Daxor Corporation、Repligen Corporation、Avantor, Inc.涨幅较大，Sharps Technology Inc.、Glucotrack, Inc.、Bionano Genomics, Inc.较为活跃，换手率分别为223.91%、9.98%、0.89%，振幅较大的相关个股有Glucotrack, Inc.、Zentek Ltd.、Daxor Corporation，振幅分别为2.52%、1.75%、1.60%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822311298756b5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822311298756b5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","LU1815336091.USD","LU0757428866.USD","RGEN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.repligen.com","stockEarnings":[{"period":"1week","weight":-0.1038},{"period":"1month","weight":-0.0465},{"period":"3month","weight":0.1221},{"period":"6month","weight":-0.1871},{"period":"1year","weight":0.0828},{"period":"ytd","weight":-0.1947}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Repligen Corporation成立于1981年5月。该公司是生物制剂生产关键产品的领先供应商。公司根据长期供应协议为主要生命科学公司生产Protein A，同时也直接向终端用户销售产品，供其生产工艺使用。公司还将其在生物制品开发方面的专业知识应用于SecreFlo的研发。SecreFlo是公司正在开发的一种合成人激素，旨在作为一种新型显像剂用于诊断胰腺炎以及潜在的多种胰腺疾病。该公司目前还有两项针对弗里德赖希氏共济失调和脊髓性肌萎缩症的早期中枢神经系统罕见病项目正在进行中，并已进入I期临床试验阶段。此外，该公司已将部分知识产权授权给Bristol-Myers Squibb Company，并从该公司在美国销售的Orencia产品净销售额中获得特许权使用费。","yearOnYearQuotes":[{"month":1,"riseRate":0.675,"avgChangeRate":0.091484},{"month":2,"riseRate":0.4,"avgChangeRate":0.02561},{"month":3,"riseRate":0.525,"avgChangeRate":0.031522},{"month":4,"riseRate":0.5,"avgChangeRate":-0.003105},{"month":5,"riseRate":0.560976,"avgChangeRate":0.045895},{"month":6,"riseRate":0.487805,"avgChangeRate":-0.008423},{"month":7,"riseRate":0.487805,"avgChangeRate":0.027782},{"month":8,"riseRate":0.575,"avgChangeRate":0.029951},{"month":9,"riseRate":0.375,"avgChangeRate":-0.036497},{"month":10,"riseRate":0.475,"avgChangeRate":0.025712},{"month":11,"riseRate":0.475,"avgChangeRate":0.032931},{"month":12,"riseRate":0.475,"avgChangeRate":-0.003719}],"exchange":"NASDAQ","name":"Repligen Corporation","nameEN":"Repligen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Repligen Corporation,RGEN,Repligen Corporation股票,Repligen Corporation股票老虎,Repligen Corporation股票老虎国际,Repligen Corporation行情,Repligen Corporation股票行情,Repligen Corporation股价,Repligen Corporation股市,Repligen Corporation股票价格,Repligen Corporation股票交易,Repligen Corporation股票购买,Repligen Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}